YOLFTbeta
Enzymatica publ AB

Enzymatica publ AB

ENZY · ST · Healthcare / Drug Manufacturers - Specialty & Generic

2.51SEK+0.05 (+2.03%)

Price History

Full chart

Market Stats

Previous Close2.46
Open2.41
Day Range2.41 – 2.60
52-Week Range1.55 – 3.40
Volume56.25K
Market Cap434.50M
P/E (TTM)0.00
Forward P/E69.93
EPS-0.19
Dividend Yield0.00%
Beta-0.40
50-Day Avg1.88
200-Day Avg2.22

About

Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care under Penzyme technology. The company was incorporated in 2007 and is headquartered in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Sana Alajmovic
  • Employees18
  • HeadquartersIdeon Science Park, Lund, Sweden, 223 70, Sweden
  • Websitehttps://enzymatica.com

Leadership

  • Ms. Sana AlajmovicChief Executive Officer
  • Mr. Holger Lembrer M.Sc.Chief Financial Officer · b. 1984
  • Mr. Bjarki StefanssonChief Scientist & Head of Production Iceland
  • Mr. Joakim Tingström NordinNordic Marketing and Sales Director · b. 1983

Financials

Income Statement

Currency: SEK2007-12-312008-12-312009-12-312010-12-312011-04-302011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue577.00K63.00K157.00K167.00K300.00K582.00K895.00K10.49M19.06M27.91M36.48M59.45M52.56M61.31M111.25M57.24M48.95M50.90M45.58M53.90M
Growth (%)--89.08%+149.21%+6.37%+79.64%+94.00%+53.78%+1071.96%+81.74%+46.42%+30.70%+62.95%-11.58%+16.64%+81.46%-48.54%-14.49%+4.00%-10.47%+18.27%
Cost of Revenue-3.00K95.09K207.00K226.00K611.00K651.00K2.33M4.17M8.49M14.25M23.12M15.76M16.41M35.29M23.89M20.49M19.04M14.86M20.78M
Gross Profit---95.09K---29.00K244.00K8.15M14.90M19.43M22.23M36.33M36.80M44.90M75.96M33.35M28.45M31.86M30.72M33.13M
Gross Margin---60.57%---4.98%27.26%77.75%78.15%69.60%60.93%61.11%70.02%73.23%68.28%58.26%58.13%62.59%67.40%61.45%
Operating Expense---20.17K--4.89M7.92M24.36M47.56M59.94M68.41M66.54M77.39M86.56M88.02M78.60M96.67M79.92M82.77M85.33M
Operating Income---74.93K---4.92M-7.67M-16.21M-32.67M-40.52M-46.18M-30.21M-40.58M-41.66M-12.06M-45.25M-68.22M-48.06M-52.05M-52.21M
Operating Margin---47.72%---845.19%-857.09%-154.53%-171.36%-145.16%-126.57%-50.82%-77.21%-67.95%-10.84%-79.04%-139.37%-94.42%-114.22%-96.86%
EBITDA---72.82K---4.90M-7.55M-16.04M-31.80M-40.38M-42.61M-24.98M-33.58M-34.51M-5.23M-38.19M-59.97M-41.12M-49.23M-46.81M
EBITDA Margin---46.38%---841.92%-843.35%-152.95%-166.83%-144.69%-116.79%-42.02%-63.89%-56.30%-4.70%-66.71%-122.52%-80.78%-108.01%-86.83%
Net Income---190.10K---4.99M-7.57M-16.21M-32.39M-40.83M-45.01M-31.45M-42.58M-40.98M-13.22M-45.39M-68.66M-49.73M-53.18M-51.89M
Net Income Margin---121.08%---856.87%-845.59%-154.52%-169.93%-146.28%-123.36%-52.90%-81.01%-66.84%-11.88%-79.30%-140.27%-97.69%-116.68%-96.27%
R&D-------2.84M5.80M7.84M12.35M14.45M20.82M28.50M22.49M24.21M26.50M15.18M15.46M15.66M
R&D as % of Total Revenue-------27.10%30.40%28.10%33.84%24.31%39.60%46.48%20.21%42.30%54.13%29.83%33.93%29.05%
Interest Expense0000069.00K32.00K30.00K198.00K445.00K1.43M536.00K2.34M1.47M804.00K889.00K997.00K2.09M1.91M1.23M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%11.86%3.58%0.29%1.04%1.59%3.93%0.90%4.45%2.39%0.72%1.55%2.04%4.10%4.18%2.28%

Balance Sheet

Currency: SEK2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets981.00K1.03M1.22M7.39M4.64M16.02M26.02M72.17M43.85M162.64M133.82M185.17M147.71M162.03M157.04M174.41M125.91M195.22M141.98M
Total Liabilities929.00K1.75M2.12M2.99M1.33M1.96M10.29M9.74M21.87M20.60M23.12M25.51M28.51M55.38M32.07M48.12M49.30M18.86M17.80M
Total Equity52.00K--901.48K4.40M3.31M14.06M15.73M62.42M21.98M141.69M110.34M159.66M119.20M106.65M124.97M126.29M76.61M176.37M124.17M
Cash----1.93M9.65M4.24M37.92M8.06M35.59M10.93M70.30M29.32M24.02M31.62M50.69M8.37M75.21M33.13M
Total Debt--1.90M-192.00K---10.94M8.57M8.31M4.78M5.57M14.47M2.60M22.32M18.08M2.20M1.02M
Net Debt--1.90M--1.74M-9.65M-4.24M-37.92M2.87M-28.59M-2.62M-65.52M-23.75M-9.55M-29.02M-28.37M9.71M-73.01M-32.11M

Cash Flow

Currency: SEK2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-101.99K--4.86M-7.25M-18.43M-40.67M-37.65M-38.43M-22.55M-28.79M-37.58M-10.65M-35.87M-64.57M-40.29M-60.51M-40.97M
Investing Cash Flow-114.75K--464.00K-3.10M-4.60M-3.92M-3.15M-19.00M-1.26M-520.00K-866.00K-4.84M-6.13M-3.72M-730.00K-393.00K-231.00K
Financing Cash Flow244.91K5.79M7.25M18.08M17.62M78.27M10.94M84.62M-846.00K88.74M-2.53M10.02M49.53M87.37M-1.39M127.65M-789.00K
Capital Expenditure114.75K14.00K464.00K3.10M4.60M3.92M3.15M13.89M1.26M520.00K866.00K4.84M6.13M3.72M730.00K393.00K231.00K
Free Cash Flow-216.74K--5.32M-10.35M-23.03M-44.58M-40.79M-52.32M-23.81M-29.31M-38.44M-15.49M-42.00M-68.28M-41.02M-60.90M-41.20M
FCF to OCF212.51%-109.56%142.75%124.96%109.63%108.36%136.13%105.61%101.81%102.30%145.41%117.10%105.76%101.81%100.65%100.56%

Earnings

Report DateMay 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Jul 22, 2014Oct 21, 2014Feb 17, 2015Apr 21, 2015Jul 21, 2015Oct 20, 2015Feb 15, 2016Apr 18, 2016Jul 18, 2016Nov 3, 2016Feb 16, 2017Apr 20, 2017Jul 20, 2017Nov 1, 2017Feb 14, 2018Apr 26, 2018Jul 17, 2018Oct 31, 2018Feb 19, 2019May 7, 2019Jul 17, 2019Nov 5, 2019Feb 13, 2020May 5, 2020Jul 16, 2020Nov 3, 2020Feb 18, 2021Apr 29, 2021Jul 16, 2021Nov 2, 2021Feb 17, 2022Apr 28, 2022Jul 19, 2022Nov 2, 2022Feb 17, 2023Apr 27, 2023Jul 18, 2023Nov 7, 2023Feb 16, 2024Apr 25, 2024Jul 18, 2024Nov 7, 2024Feb 18, 2025Apr 29, 2025Jul 27, 2025Oct 30, 2025Feb 16, 2026Apr 27, 2026Jul 17, 2026
EPS Estimate------0.03-0.02--0.03-0.06-0.03--0.04-0.03-0.01-0.01-0.01-0.01-0.01-0.16-0.01-0.01-0.01-0.01-0.08-0.01--0.01---0.040.02----0.13-----------------
EPS Actual-0.11-0.16-0.23-0.20-0.23-0.05-0.03-0.43-0.04-0.05-0.05-0.40-0.04-0.02-0.01-0.02-0.01-0.01-0.04-0.06-0.01-0.02-0.01-0.01-0.09-0.01-0.01-0.04-0.01-0.01-0.01-0.00-0.06-0.14-0.04-0.01-0.12-0.10-0.08-0.14-0.09-0.07-0.06-0.09-0.11-0.08-0.04-0.05-0.07-0.06-0.03-0.05-0.06-0.05
Surprise------66.67%-50.00%--33.33%16.67%-66.67%-0.00%33.33%0.00%-100.00%0.00%0.00%-300.00%62.50%0.00%-100.00%0.00%0.00%-12.50%0.00%--300.00%--75.00%-111.00%-----192.31%-----------------
Timing-----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap434.50M
Enterprise Value413.67M
Trailing P/E0.00
Forward P/E69.93
PEG Ratio0.00
Price / Sales8.37
Price / Book4.20
EPS-0.19
Book Value0.405
Revenue (TTM)51.93M
Gross Profit (TTM)29.96M
EBITDA-42.27M
Profit Margin-88.30%
Operating Margin-176.83%
Return on Equity-37.90%
Return on Assets-19.99%
Shares Outstanding242.74M
Shares Float175.75M
Beta-0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 23, 2024903:835
  • Aug 5, 20222762:2761
  • Nov 9, 2018451:439
  • Apr 18, 2016290:263
  • Mar 10, 2014265:257
  • May 22, 201252:51